Predictor | Total number cases (n = 46,779) | aOR Any treatment (n = 46,297) | aOR Surgery (n = 43,653) | aOR Mastectomy (n = 18,283) | aOR Conserving surgery (n = 25,327) | aOR Radiotherapy (n = 31,132) | aOR Systemic therapy (n = 39,231) |
---|---|---|---|---|---|---|---|
Country of birth | Australia (n = 30,344) | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 |
China (mainland) (n = 1045) | 0.463 (0.257,0,835) | 1.021 (0.744,1.401) | 1.625 (1.430,1.846) | 0.605 (0.531,0.689) | 0.610 (0.535,0.695) | 0.715 (0.605,0.845) | |
Germany (n = 430) | 0.795 (0.315,2.004) | 0.835 (0.554,1.258) | 0.838 (0.683,1.028) | 1.146 (0.935,1.405) | 1.134 (0.916,1.404) | 0.683 (0.535,0.871) | |
Greece (n = 502) | 0.885 (0.398,1.965) | 0.792 (0.553,1.132) | 0.757 (0.624,0.917) | 1.254 (1.073,1.516) | 1.313 (1.076,1.603) | 0.984 (0.768,1.260) | |
Italy (n = 733) | 2.279 (0.897,5.793) | 1.059 (0.766,1.465) | 0.734 (0.626,0.861) | 1.403 (1.198,1.644) | 1.431 (1.210,1.692) | 1.153 (0.933,1.425) | |
Lebanon (n = 591) | 2.399 (0.579,9.935) | 1.116 (0.750,1.660) | 0.614 (0.512,0.737) | 1.666 (1.393,1.994) | 1.518 (1.242,1.857) | 1.034 (0.802,1.333) | |
New Zealand (n = 1005) | 0.484 (0.262,0.892) | 0.854 (0.634,1.151) | 1.066 (0.934,1.217) | 0.918 (0.804,1.048) | 0.938 (0.815,1.080) | 0.961 (0.798,1.156) | |
Philippines (n = 767) | 1.026 (0.373,2.824) | 1.254 (0.846,1.858) | 1.477 (1.273,1.714) | 0.693 (0.596,0.807) | 0.646 (0.555,0.752) | 1.009 (0.811,1.256) | |
United Kingdom (n = 3299) | 0.917 (0.633,1.328) | 0.929 (0.787,1.097) | 0.911 (0.844,0.984) | 1.080 (1.001,1.167) | 1.130 (1.042,1.226) | 0.986 (0.892,1.091) | |
Vietnam (n = 482) | 1.327 (0.315,5.593) | 1.178 (0.709,1.955) | 1.542 (1.278,1.859) | 0.643 (0.532,0.778) | 0.646 (0.534,0.781) | 0.903 (0.695,1.174) | |
Other mainly English speaking (n = 838) | 0.827 (0.370,1.851) | 1.125 (0.789,1.605) | 1.130 (0.978,1.305) | 0.893 (0.772,1.033) | 0.948 (0.812,1.107) | 0.845 (0.696,1.027) | |
Other mainly non-English speaking (n = 6743) | 0.491 (0.385,0.627) | 0.750 (0.667,0.843) | 0.958 (0.906,1.014) | 0.984 (0.930,1.041) | 0.953 (0.899,1.011) | 0.801 (0.745,0.863) | |
Age at diagnosis (18 + years) | Continuous (n = 46,779) | 0.913 (0.903,0.923) | 0.932 (0.926,0.937) | 1.013 (1.010,1.017) | 0.965 (0.962,0.968) | 0.911 (0.908,0.915) | 0.942 (0.938,0.945) |
SEIFA SES Disadvantage | 1 (most) (ref.) (n = 8346) | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 |
2 (n = 8591) | 0.983 (0.754,1.281) | 1.157 (1.016,1.317) | 0.962 (0.903,1.026) | 1.080 (1.012,1.152) | 1.081 (1.012,1.155) | 1.007 (0.926,1.095) | |
3 (n = 8847) | 1.229 (0.919,1.645) | 1.249 (1.094,1.427) | 0.967 (0.908,1.031) | 1.096 (1.028,1.168) | 1.121 (1.049,1.198) | 1.050 (0.965,1.141) | |
4 (n = 9751) | 1.370 (1.018, 1.844) | 1.176 (1.032,1.340) | 0.926 (0.870,0.985) | 1.127 (1.058,1.200) | 1.222 (1.145,1.305) | 1.132 (1.041,1.230) | |
5 (least) (n = 11,244) | 2.068 (1.480,2.889) | 1.484 (1.296,1.700) | 0.928 (0.891,1.012) | 1.158 (1.090,1.232) | 1.309 (1.228,1.396) | 1.153 (1.063,1.251) | |
Year of diagnosis | Continuous (2003 to 2016) (n = 46,779) | 0.995 (0.991,1.000) | 0.982 (0.971,0.992) | 0.981 (0.976,0.985) | 1.015 (1.010,1.020) | 0.644 (0.595,0.698) | 1.054 (1.047,1.061) |
Stage (degree of spread) | Local (ref.) (n = 25,149) | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 |
Regional (n = 18,512) | 0.806 (0.610,1.065) | 0.732 (0.660,0.813) | 2.809 (2.699,2.923) | 0.342 (0.329,0.356) | 1.355 (1.298,1.414) | 4.277 (4.007,4.565) | |
Distant (n = 3118) | 0.058 (0.046,0.073) | 0.030 (0.027,0.033) | 1.010 (0.931,1.097) | 0.114 (0.103,0.125) | 0.644 (0.595,0.698) | 2.356 (2.111,2.631) | |
Comorbidity Index (Charlson) | 0 (ref.) (n = 45,486) | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 |
> 0 (n = 1293) | 0.246 (0.191,0.317) | 0.314 (0.266,0.371) | 0.874 (0.774,0.986) | 0.632 (0.558,0.717) | 0.472 (0.416,0.535) | 0.680 (0.595,0.778) |